Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression

Pierre G Thirion; Mary T Dunne; Paul J Kelly; Aileen Flavin; Joe M O'Sullivan; Dayle Hacking; Wojciech Sasiadek; Cormac Small; Maeve M Pomeroy; Joseph Martin; Orla McArdle; Imelda Parker; Lydia S O'Sullivan; Aoife M Shannon; Angela Clayton-Lea; Conor D Collins; Michael R Stevenson; Alberto Alvarez-Iglesias; John G Armstrong; Michael Moriarty

doi:10.1038/s41416-020-0768-z

Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression

Pierre G Thirion, Mary T Dunne, Paul J Kelly, Aileen Flavin, Joe M O'Sullivan, Dayle Hacking, Wojciech Sasiadek, Cormac Small, Maeve M Pomeroy, Joseph Martin, Orla McArdle, Imelda Parker, Lydia S O'Sullivan, Aoife M Shannon, Angela Clayton-Lea, Conor D Collins, Michael R Stevenson, Alberto Alvarez-Iglesias, John G Armstrong, Michael Moriarty

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

BACKGROUND: The optimal EBRT schedule for MSCC is undetermined. Our aim was to determine whether a single fraction (SF) was non-inferior to five daily fractions (5Fx), for functional motor outcome.

METHODS: Patients not proceeding with surgical decompression in this multicentre non-inferiority, Phase 3 trial were randomised to 10 Gy/SF or 20 Gy/5Fx. A change in mobility from baseline to 5 weeks for each patient, was evaluated by a Modified Tomita score: 1 = 'Walk unaided', 2 = 'With walking aid' and 3 = 'Bed-bound'. The margin used to establish non-inferiority was a detrimental change of -0.4 in the mean difference between arms.

RESULTS: One-hundred and twelve eligible patients were enrolled. Seventy-three patients aged 30-87 were evaluated for the primary analysis. The 95% CI for the difference in the mean change in mobility scores between arms was -0.12 to 0.6. Since -0.4 is not included in the interval, there is evidence that 10 Gy/SF is non-inferior to 20 Gy/5Fx. One grade 3 AE was reported in the 5Fx arm. Twelve (26%) patients in the 5Fx arm had a Grade 2-3 AE compared with six (11%) patients in the SF arm (p = 0.093).

CONCLUSION: For mobility preservation, one 10-Gy fraction is non-inferior to 20 Gy in five fractions, in patients with MSCC not proceeding with surgical decompression.

CLINICAL TRIAL REGISTRATION: Cancer Trials Ireland ICORG 05-03; NCT00968643; EU-20952.

Original language	English
Journal	British Journal of Cancer
Early online date	11 Mar 2020
DOIs	https://doi.org/10.1038/s41416-020-0768-z
Publication status	Early online date - 11 Mar 2020
Externally published	Yes

Access to Document

10.1038/s41416-020-0768-zLicence: Unspecified

Fingerprint Dive into the research topics of 'Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression'. Together they form a unique fingerprint.

Cite this

Thirion, P. G., Dunne, M. T., Kelly, P. J., Flavin, A., O'Sullivan, J. M., Hacking, D., Sasiadek, W., Small, C., Pomeroy, M. M., Martin, J., McArdle, O., Parker, I., O'Sullivan, L. S., Shannon, A. M., Clayton-Lea, A., Collins, C. D., Stevenson, M. R., Alvarez-Iglesias, A., Armstrong, J. G., & Moriarty, M. (2020). Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression. British Journal of Cancer. https://doi.org/10.1038/s41416-020-0768-z

Thirion, Pierre G ; Dunne, Mary T ; Kelly, Paul J ; Flavin, Aileen ; O'Sullivan, Joe M ; Hacking, Dayle ; Sasiadek, Wojciech ; Small, Cormac ; Pomeroy, Maeve M ; Martin, Joseph ; McArdle, Orla ; Parker, Imelda ; O'Sullivan, Lydia S ; Shannon, Aoife M ; Clayton-Lea, Angela ; Collins, Conor D ; Stevenson, Michael R ; Alvarez-Iglesias, Alberto ; Armstrong, John G ; Moriarty, Michael. / Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression. In: British Journal of Cancer. 2020.

@article{04eb70b3a13e4edc90668734fc514126,

title = "Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression",

abstract = "BACKGROUND: The optimal EBRT schedule for MSCC is undetermined. Our aim was to determine whether a single fraction (SF) was non-inferior to five daily fractions (5Fx), for functional motor outcome.METHODS: Patients not proceeding with surgical decompression in this multicentre non-inferiority, Phase 3 trial were randomised to 10 Gy/SF or 20 Gy/5Fx. A change in mobility from baseline to 5 weeks for each patient, was evaluated by a Modified Tomita score: 1 = 'Walk unaided', 2 = 'With walking aid' and 3 = 'Bed-bound'. The margin used to establish non-inferiority was a detrimental change of -0.4 in the mean difference between arms.RESULTS: One-hundred and twelve eligible patients were enrolled. Seventy-three patients aged 30-87 were evaluated for the primary analysis. The 95% CI for the difference in the mean change in mobility scores between arms was -0.12 to 0.6. Since -0.4 is not included in the interval, there is evidence that 10 Gy/SF is non-inferior to 20 Gy/5Fx. One grade 3 AE was reported in the 5Fx arm. Twelve (26%) patients in the 5Fx arm had a Grade 2-3 AE compared with six (11%) patients in the SF arm (p = 0.093).CONCLUSION: For mobility preservation, one 10-Gy fraction is non-inferior to 20 Gy in five fractions, in patients with MSCC not proceeding with surgical decompression.CLINICAL TRIAL REGISTRATION: Cancer Trials Ireland ICORG 05-03; NCT00968643; EU-20952.",

author = "Thirion, {Pierre G} and Dunne, {Mary T} and Kelly, {Paul J} and Aileen Flavin and O'Sullivan, {Joe M} and Dayle Hacking and Wojciech Sasiadek and Cormac Small and Pomeroy, {Maeve M} and Joseph Martin and Orla McArdle and Imelda Parker and O'Sullivan, {Lydia S} and Shannon, {Aoife M} and Angela Clayton-Lea and Collins, {Conor D} and Stevenson, {Michael R} and Alberto Alvarez-Iglesias and Armstrong, {John G} and Michael Moriarty",

year = "2020",

month = mar,

day = "11",

doi = "10.1038/s41416-020-0768-z",

language = "English",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

}

Thirion, PG, Dunne, MT, Kelly, PJ, Flavin, A, O'Sullivan, JM, Hacking, D, Sasiadek, W, Small, C, Pomeroy, MM, Martin, J, McArdle, O, Parker, I, O'Sullivan, LS, Shannon, AM, Clayton-Lea, A, Collins, CD, Stevenson, MR, Alvarez-Iglesias, A, Armstrong, JG & Moriarty, M 2020, 'Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression', British Journal of Cancer. https://doi.org/10.1038/s41416-020-0768-z

Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression. / Thirion, Pierre G; Dunne, Mary T; Kelly, Paul J; Flavin, Aileen; O'Sullivan, Joe M; Hacking, Dayle; Sasiadek, Wojciech; Small, Cormac; Pomeroy, Maeve M; Martin, Joseph; McArdle, Orla; Parker, Imelda; O'Sullivan, Lydia S; Shannon, Aoife M; Clayton-Lea, Angela; Collins, Conor D; Stevenson, Michael R; Alvarez-Iglesias, Alberto; Armstrong, John G; Moriarty, Michael.

In: British Journal of Cancer, 11.03.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression

AU - Thirion, Pierre G

AU - Dunne, Mary T

AU - Kelly, Paul J

AU - Flavin, Aileen

AU - O'Sullivan, Joe M

AU - Hacking, Dayle

AU - Sasiadek, Wojciech

AU - Small, Cormac

AU - Pomeroy, Maeve M

AU - Martin, Joseph

AU - McArdle, Orla

AU - Parker, Imelda

AU - O'Sullivan, Lydia S

AU - Shannon, Aoife M

AU - Clayton-Lea, Angela

AU - Collins, Conor D

AU - Stevenson, Michael R

AU - Alvarez-Iglesias, Alberto

AU - Armstrong, John G

AU - Moriarty, Michael

PY - 2020/3/11

Y1 - 2020/3/11

N2 - BACKGROUND: The optimal EBRT schedule for MSCC is undetermined. Our aim was to determine whether a single fraction (SF) was non-inferior to five daily fractions (5Fx), for functional motor outcome.METHODS: Patients not proceeding with surgical decompression in this multicentre non-inferiority, Phase 3 trial were randomised to 10 Gy/SF or 20 Gy/5Fx. A change in mobility from baseline to 5 weeks for each patient, was evaluated by a Modified Tomita score: 1 = 'Walk unaided', 2 = 'With walking aid' and 3 = 'Bed-bound'. The margin used to establish non-inferiority was a detrimental change of -0.4 in the mean difference between arms.RESULTS: One-hundred and twelve eligible patients were enrolled. Seventy-three patients aged 30-87 were evaluated for the primary analysis. The 95% CI for the difference in the mean change in mobility scores between arms was -0.12 to 0.6. Since -0.4 is not included in the interval, there is evidence that 10 Gy/SF is non-inferior to 20 Gy/5Fx. One grade 3 AE was reported in the 5Fx arm. Twelve (26%) patients in the 5Fx arm had a Grade 2-3 AE compared with six (11%) patients in the SF arm (p = 0.093).CONCLUSION: For mobility preservation, one 10-Gy fraction is non-inferior to 20 Gy in five fractions, in patients with MSCC not proceeding with surgical decompression.CLINICAL TRIAL REGISTRATION: Cancer Trials Ireland ICORG 05-03; NCT00968643; EU-20952.

AB - BACKGROUND: The optimal EBRT schedule for MSCC is undetermined. Our aim was to determine whether a single fraction (SF) was non-inferior to five daily fractions (5Fx), for functional motor outcome.METHODS: Patients not proceeding with surgical decompression in this multicentre non-inferiority, Phase 3 trial were randomised to 10 Gy/SF or 20 Gy/5Fx. A change in mobility from baseline to 5 weeks for each patient, was evaluated by a Modified Tomita score: 1 = 'Walk unaided', 2 = 'With walking aid' and 3 = 'Bed-bound'. The margin used to establish non-inferiority was a detrimental change of -0.4 in the mean difference between arms.RESULTS: One-hundred and twelve eligible patients were enrolled. Seventy-three patients aged 30-87 were evaluated for the primary analysis. The 95% CI for the difference in the mean change in mobility scores between arms was -0.12 to 0.6. Since -0.4 is not included in the interval, there is evidence that 10 Gy/SF is non-inferior to 20 Gy/5Fx. One grade 3 AE was reported in the 5Fx arm. Twelve (26%) patients in the 5Fx arm had a Grade 2-3 AE compared with six (11%) patients in the SF arm (p = 0.093).CONCLUSION: For mobility preservation, one 10-Gy fraction is non-inferior to 20 Gy in five fractions, in patients with MSCC not proceeding with surgical decompression.CLINICAL TRIAL REGISTRATION: Cancer Trials Ireland ICORG 05-03; NCT00968643; EU-20952.

U2 - 10.1038/s41416-020-0768-z

DO - 10.1038/s41416-020-0768-z

M3 - Article

C2 - 32157242

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

ER -